In pursuit of Alzheimer's, cancer, growing Alector lands $133 million
July 25, 2018 at 09:29 AM EDT
The South San Francisco biotech company is attacking Alzheimer's and other neurodegenerative diseases as well as cancer by boosting the immune system.
